50 related articles for article (PubMed ID: 30465924)
1. Piperlongumine (piplartine) and analogues: Antiproliferative microtubule-destabilising agents.
Meegan MJ; Nathwani S; Twamley B; Zisterer DM; O'Boyle NM
Eur J Med Chem; 2017 Jan; 125():453-463. PubMed ID: 27689728
[TBL] [Abstract][Full Text] [Related]
2. Sustainable Syntheses of (-)-Jerantinines A & E and Structural Characterisation of the Jerantinine-Tubulin Complex at the Colchicine Binding Site.
Smedley CJ; Stanley PA; Qazzaz ME; Prota AE; Olieric N; Collins H; Eastman H; Barrow AS; Lim KH; Kam TS; Smith BJ; Duivenvoorden HM; Parker BS; Bradshaw TD; Steinmetz MO; Moses JE
Sci Rep; 2018 Jul; 8(1):10617. PubMed ID: 30006510
[TBL] [Abstract][Full Text] [Related]
3. Noscapine-Amino Acid Conjugates Suppress the Progression of Cancer Cells.
Awasthi A; Kumar N; Mishra A; Ravi R; Dalal A; Shankar S; Chandra R
ACS Pharmacol Transl Sci; 2022 Dec; 5(12):1292-1304. PubMed ID: 36524011
[TBL] [Abstract][Full Text] [Related]
4. Aqueous extract of ginger shows antiproliferative activity through disruption of microtubule network of cancer cells.
Choudhury D; Das A; Bhattacharya A; Chakrabarti G
Food Chem Toxicol; 2010 Oct; 48(10):2872-80. PubMed ID: 20647029
[TBL] [Abstract][Full Text] [Related]
5. Noscapine inhibits tumor growth with little toxicity to normal tissues or inhibition of immune responses.
Ke Y; Ye K; Grossniklaus HE; Archer DR; Joshi HC; Kapp JA
Cancer Immunol Immunother; 2000 Jul; 49(4-5):217-25. PubMed ID: 10941904
[TBL] [Abstract][Full Text] [Related]
6. Identification of C-6 as a New Site for Linker Conjugation to the Taccalonolide Microtubule Stabilizers.
Du L; Risinger AL; Yee SS; Ola ARB; Zammiello CL; Cichewicz RH; Mooberry SL
J Nat Prod; 2019 Mar; 82(3):583-588. PubMed ID: 30799622
[TBL] [Abstract][Full Text] [Related]
7. Noscapine and Apoptosis in Breast and Other Cancers.
Calaf GM; Crispin LA; Quisbert-Valenzuela EO
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542508
[TBL] [Abstract][Full Text] [Related]
8. Exploration of efficacy, cellular responses, and safety profile of novel 9-(3-Pyridyl) noscapine derivatives as promising anticancer candidates.
Dash SG; Kantevari S; Kumar Naik P
J Biomol Struct Dyn; 2023 Oct; ():1-13. PubMed ID: 37897183
[TBL] [Abstract][Full Text] [Related]
9. Noscapine, an Emerging Medication for Different Diseases: A Mechanistic Review.
Rahmanian-Devin P; Baradaran Rahimi V; Jaafari MR; Golmohammadzadeh S; Sanei-Far Z; Askari VR
Evid Based Complement Alternat Med; 2021; 2021():8402517. PubMed ID: 34880922
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of anti-angiogenic effects of noscapine derivatives.
Meher RK; Naik MR; Bastia B; Naik PK
Bioinformation; 2018; 14(5):236-240. PubMed ID: 30108421
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, and Functional Studies on Noscapine and Cotarnine Amino Acid Derivatives as Antitumor Agents.
Davarzani Z; Salehi P; Asghari SM; Bararjanian M; Hamrahi Mohsen A; Dehghan Harati H
ACS Omega; 2023 Dec; 8(48):45502-45509. PubMed ID: 38075843
[TBL] [Abstract][Full Text] [Related]
12. The Anticancer Effect of Natural Plant Alkaloid Isoquinolines.
Yun D; Yoon SY; Park SJ; Park YJ
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562110
[TBL] [Abstract][Full Text] [Related]
13. Noscapine, a Non-addictive Opioid and Microtubule-Inhibitor in Potential Treatment of Glioblastoma.
Altinoz MA; Topcu G; Hacimuftuoglu A; Ozpinar A; Ozpinar A; Hacker E; Elmaci İ
Neurochem Res; 2019 Aug; 44(8):1796-1806. PubMed ID: 31292803
[TBL] [Abstract][Full Text] [Related]
14. Insights into the structure and tubulin-targeted anticancer potential of N-(3-bromobenzyl) noscapine.
Cheriyamundath S; Mahaddalkar T; Reddy Nagireddy PK; Sridhar B; Kantevari S; Lopus M
Pharmacol Rep; 2019 Feb; 71(1):48-53. PubMed ID: 30465924
[TBL] [Abstract][Full Text] [Related]
15. Taking aim at a dynamic target: Noscapinoids as microtubule-targeted cancer therapeutics.
Lopus M; Naik PK
Pharmacol Rep; 2015 Feb; 67(1):56-62. PubMed ID: 25560576
[TBL] [Abstract][Full Text] [Related]
16. Elucidation of the Tubulin-targeted Mechanism of Action of 9-(3-pyridyl) Noscapine.
Pradhan S; Mahaddalkar T; Choudhary S; Manhcukonda N; Nagireddy PR; Kantevari S; Lopus M
Curr Top Med Chem; 2017; 17(22):2569-2574. PubMed ID: 28056737
[TBL] [Abstract][Full Text] [Related]
17. Rational design of novel microtubule targeting anticancer drugs N-imidazopyridine noscapinoids: Chemical synthesis and experimental evaluation based on in vitro using breast cancer cells and in vivo using xenograft mice model.
Pragyandipta P; Pedapati RK; Reddy PK; Nayek A; Meher RK; Guru SK; Kantevari S; Naik PK
Chem Biol Interact; 2023 Sep; 382():110606. PubMed ID: 37330181
[TBL] [Abstract][Full Text] [Related]
18. Tubulin binding, protein-bound conformation in solution, and antimitotic cellular profiling of noscapine and its derivatives.
Bennani YL; Gu W; Canales A; Díaz FJ; Eustace BK; Hoover RR; Jiménez-Barbero J; Nezami A; Wang T
J Med Chem; 2012 Mar; 55(5):1920-5. PubMed ID: 22320354
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
